Skip to main content

Advertisement

Log in

Gastrointestinale Tumoren

Adjuvante Chemotherapie des Pankreas-Ca

  • journal club
  • Published:
Gastro-News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

1

Literatur

  1. Neoptolemos JP et al. N Engl J Med 2004;350(12): p. 1200–10

    Article  CAS  PubMed  Google Scholar 

  2. Neoptolemos JP et al. JAMA 2010;304(10): p. 1073–81

    Article  CAS  PubMed  Google Scholar 

  3. Cunningham D et al. J Clin Oncol 2009;27(33): p. 5513–8

    Article  CAS  PubMed  Google Scholar 

  4. Uesaka K et al. Lancet 2016;388(10041): p. 248–57

    Article  CAS  PubMed  Google Scholar 

  5. Tempero MA et al. J Natl Compr Canc Netw 2017;15(8): p. 1028–61

    Article  PubMed  Google Scholar 

Literatur

  • Neoptolemos JP et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet 2017;389:1011–24

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruediger Göß Arzt.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Göß, R., Scheufele, F. & Friess, H. Adjuvante Chemotherapie des Pankreas-Ca. Gastro-News 5, 22–23 (2018). https://doi.org/10.1007/s15036-018-0315-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-018-0315-4

Navigation